The n3-polyunsaturated fatty acid docosahexaenoic acid induces immunogenic cell death in human cancer cell lines via pre-apoptotic calreticulin exposure

  • Romina Molinari
  • Donatella D’Eliseo
  • Laura Manzi
  • Lello Zolla
  • Francesca Velotti
  • Nicolò Merendino
Short communication

Abstract

Some anticancer chemotherapeutics, such as anthracyclines and oxaliplatin, elicit immunogenic apoptosis, meaning that dying cancer cells are engulfed by dendritic cells and tumor antigens are efficiently presented to CD8+ T cells, which control residual tumor cells. Immunogenic apoptosis is characterized by pre-apoptotic cell surface exposure of calreticulin (CRT), which usually resides into the endoplasmic reticulum. We investigated the ability of the n3-polyunsaturated fatty acid docosahexaenoic acid (22:6n3, DHA) to induce pre-apoptotic CRT exposure on the surface of the human PaCa-44 pancreatic and EJ bladder cancer cell lines. Cells were treated with 150 μM DHA for different time periods, and, by immunoblot and immunofluorescence, we showed that DHA induced CRT exposure, before the apoptosis-associated phosphatidylserine exposure. As for the known immunogenic compounds, CRT exposure was inhibited by the antioxidant GSH, the pan-caspase zVAD-FMK, and caspase-8 IETD-FMK inhibitor. We provide the first evidence that DHA induces CRT exposure, representing thus a novel potential anticancer immunogenic chemotherapeutic agent.

Keywords

Docosahexaenoic acid Calreticulin Immunogenic apoptosis Immunochemotherapy 

References

  1. 1.
    Lake RA, Robinson WS (2005) Immunotherapy and chemotherapy—a practical partnership. Nat Rev Cancer 5:397–405PubMedCrossRefGoogle Scholar
  2. 2.
    Haynes NM, van der Most RG, Lake RA, Smyth MJ (2008) Immunogenic anti-cancer chemotherapy as an emerging concept. Curr Opin Immunol 20:545–571PubMedCrossRefGoogle Scholar
  3. 3.
    Dunn GP, Bruce AT, Ikeda H et al (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3:991–998PubMedCrossRefGoogle Scholar
  4. 4.
    Zitvogel L, Kepp O, Senovilla L et al (2010) Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway. Clin Cancer Res 16:3100–3104PubMedCrossRefGoogle Scholar
  5. 5.
    Casares N, Pequignot MO, Tesniere A et al (2005) Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 202:1691–1701PubMedCrossRefGoogle Scholar
  6. 6.
    Obeid M, Tesniere A, Ghiringhelli F et al (2007) Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13:54–61PubMedCrossRefGoogle Scholar
  7. 7.
    Panaretakis T, Kepp O, Brockmeier U et al (2009) Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J 28:578–590PubMedCrossRefGoogle Scholar
  8. 8.
    Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A (2004) Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 79:935–945PubMedGoogle Scholar
  9. 9.
    Colas S, Paon L, Denis F et al (2004) Enhanced radiosensitivity of rat autochthonous mammary tumors by dietary docosahexaenoic acid. Int J Cancer 109:449–454PubMedCrossRefGoogle Scholar
  10. 10.
    Bougnoux P, Hajjaji N, Ferrasson MN et al (2009) Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. Br J Cancer 101:1978–1985PubMedCrossRefGoogle Scholar
  11. 11.
    Bradley MO, Webb NL, Anthony FH et al (2001) Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel. Clin Cancer Res 7:3229–3238PubMedGoogle Scholar
  12. 12.
    El-Mesery M, Al-Gayyar M, Salem H et al (2009) Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides. Cell Div 4:6–23PubMedGoogle Scholar
  13. 13.
    Serini S, Piccioni E, Merendino N, Calviello G (2009) Dietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancer. Apoptosis 14:135–152PubMedCrossRefGoogle Scholar
  14. 14.
    Merendino N, Molinari R, Loppi B, Pessina G, D’ Aquino M, Tomassi G, Velotti F (2003) Induction of apoptosis in human pancreatic cancer cells by docosahexaenoic acid. Ann NY Acad Sci 1010:361–364PubMedCrossRefGoogle Scholar
  15. 15.
    Merendino N, Loppi B, D’Aquino M, Molinari R, Pessina G, Romano C, Velotti F (2005) Docosahexaenoic acid induces apoptosis in the human PaCa-44 pancreatic cancer cell line by active reduced glutathione extrusion and lipid peroxidation. Nutr Cancer 52:225–233PubMedCrossRefGoogle Scholar
  16. 16.
    Kang KS, Wang P, Yamabe N et al (2010) Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase-8 activation. PLoS One 5:e10296PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Romina Molinari
    • 1
  • Donatella D’Eliseo
    • 1
    • 2
  • Laura Manzi
    • 1
  • Lello Zolla
    • 1
  • Francesca Velotti
    • 1
    • 2
  • Nicolò Merendino
    • 1
  1. 1.Department of Ecological and Biological Sciences (DEB)Tuscia UniversityViterboItaly
  2. 2.Centro Ricerca SperimentaleRegina Elena Cancer InstituteRomeItaly

Personalised recommendations